Top 93 alternative sites to eurekatherapeutics.com
-
sanotize.com
-
symic.bio
-
triumvira.com
-
sanotize.com
-
lineagecell.com
-
tessacell.com
-
abcentra.com
-
adaptimmune.com
-
cellectis.com
-
mavericktx.com
-
allogene.com
-
blackthornrx.com
-
cariboubio.com
-
formatherapeutics.com
-
rapt.com
-
treefrog.fr
-
atossatherapeutics.com
-
epizyme.com
-
connectbiopharm.com
-
immunitybio.com
-
harpoontx.com
-
tracttherapeutics.com
-
magentatx.com
-
sagerx.com
-
epirium.com
-
hookipapharma.com
-
oncternal.com
-
tcr2.com
-
cardiffoncology.com
-
mozart-tx.com
-
muvon-therapeutics.com
-
americangene.com
-
bonetherapeutics.com
-
procella.se
-
oysterpointrx.com
-
bioeclipse.com
-
gammadeltatx.com
-
spiraltx.com
-
tcbiopharm.com
-
altimmune.com
-
amphera.nl
-
iksuda.com
-
helixbiopharma.com
-
ikenaoncology.com
-
cuebiopharma.com
-
firstwavebio.com
-
g1therapeutics.com
-
askbio.com
-
actris.sg
-
repertoire.com
-
antlera.com
-
medicago.com
-
rebiotix.com
-
canprevent.com
-
vtvtherapeutics.com
-
pharnext.com
-
interna-technologies.com
-
atarabio.com
-
radiomedix.com
-
liontcr.com
-
audiontherapeutics.com
-
alkahest.com
-
celularity.com
-
byondis.com
-
davolterra.com
-
polypid.com
-
sola-bio.com
-
cellestia.com
-
bluefieldproject.org
-
americancollegeofbankruptcy.com
-
nkartatx.com
-
adicetbio.com
-
amunix.com
-
ltcreit.com
-
cgoncology.com
-
neoleukin.com
-
vir.bio
-
plexxikon.com
-
eurekaconnectme.com
-
blademed.com
-
dynavax.com
-
allakos.com
-
kitzlinger.de
-
tempesttx.com
-
chinooktx.com
-
ultragenyx.com
-
iwirc.com
-
corvuspharma.com
-
orphomed.com
-
geron.com
-
cpii.com
-
novomedix.com
-
zosanopharma.com
SaNotize - The Company - Sanotize
Innovative biotech company using its patented nitric oxide releasing solution to **** viruses, bacteria and fungal infections.
Subscribe to our mailing list
Triumvira Immunologics - Triumvira Immunologics | Car-T, TCR, TAC Therapies and Immunotherapy
... Read more »
SaNotize - The Company - Sanotize
Innovative biotech company using its patented nitric oxide releasing solution to **** viruses, bacteria and fungal infections.
Home - Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
Tessa Therapeutics | Cancer Immunotherapy Treatments
Cure cancers with our innovative and widely accessible immunotherapies. Tessa Therapeutics is a clinical-stage biotechnology company focused on the development of autologous and allogeneic cell therapies for a broad range of cancers.
Abcentra - Therapeutics
Abcentra is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for cardiovascular and inflammatory diseases.
Adaptimmune Therapeutics plc
Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients
Home | Cellectis
Cellectis is a clinical-stage biopharmaceutical company developing the Next-Generation CAR T-Cells to Cure Cancer
Maverick Therapeutics | Next Gen T-cell Therapeutics And Engagement
Maverick Therapeutics is a preclinical stage biotech company founded by MPM that is developing a novel class of T cell-redirecting antibody therapeutics.
Author: Razorfrog Web Design
THE NEXT REVOLUTIONIN CELL THERAPY
A clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCART™) therapies for cancer.
Neurobehavioral Disorder **** Development | BlackThorn Therapeutics
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company developing novel, targeted treatments for neurobehavioral disorders. Learn more.
Caribou Biosciences | Developing Sophisticated Allogeneic Cell Therapies
Caribou is a clinical-stage biopharmaceutical company focused on developing genome-edited allogeneic cell therapies for devastating human diseases.
Forma Therapeutics
Forma Therapeutics is a clinical-stage biopharmaceutical company focused on therapeutics to transform the lives of patients with rare hematologic diseases and cancers.
Homepage - RAPT Therapeutics
RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by a bold mission—to conquer cancer and inflammatory disease in our lifetime. Our cutting-edge science is fully focused on developing **** therapeutics that intelligently target key drivers of the immune system to transform the treatment of cancer and inflammation, and improve and empower countless lives. Join us …
TreeFrog Therapeutics I iPS-derived Cell Therapies I Cell Therapy for All
TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable to cure millions of patients.
Atossa Therapeutics - A Clinical-Stage Biopharmaceutical Company
Atossa Therapeutics is a clinical-stage biopharmaceutical company focusing on **** cancer treatment and other **** conditions.
Home - Epizyme
Epizyme is a clinical stage biopharmaceutical company creating novel epigenetic therapies for people with cancer
Connect Biopharma - Next-Generation Therapeutics for T Cell-Driven Inflammatory Diseases
Connect Biopharma is a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research.
Other sites like eurekatherapeutics com
Immunotherapy by ImmunityBio - Cell Therapy for Cancer
ImmunityBio is dedicated to conquering cancer. We develop therapies that **** disease, not the immune system. Learn about our investigational immunotherapy and cell therapy products.
Author: Dr Patrick Soon-Shiong Executive Chairman; ImmunityBio
Harpoon Therapeutics | Immuno-oncology | TriTAC™
Harpoon Therapeutics is an immuno-oncology company using a proprietary technology platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and other diseases.
Restoring Immune Balance ™ | TRACT Therapeutics, Inc.
TRACT Therapeutics, Inc. has developed a revolutionary therapy that utilizes a patient's own T regulatory cells to better control their immune system after an **** transplant.
Bringing The Curative Power of Stem Cell Transplants to More Patients
Magenta Therapeutics is a clinical-stage biotech developing therapeutics to curative power of stem cell transplants to more patients
Biopharmaceutical Company for Brain Health Disorders - Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company developing novel therapies for brain health disorders with Depression, Neurology and Neuropsychiatric franchise programs.
Epirium Bio
Epirium Bio is a clinical-stage biopharmaceutical company developing therapeutics that promote mitochondrial biogenesis and function through a novel mechanism of action discovered by the company.
Hookipa Pharma - Supercharging Immunotherapy
Hookipa Pharma Inc. is a clinical stage company developing products to prevent and cure infectious diseases and cancer. With this goal in mind, we created unique and cutting-edge technologies to reprogram and stimulate the immune system.
Oncternal Therapeutics | Home
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. We’re committed to translate pioneering areas of cancer research into approved therapies that can be used to treat multiple cancer types.
TCR² Therapeutics
TCR² is developing a new generation of T cell therapies for patients suffering from cancer. Our proprietary TRuC™ (TCR Fusion Construct) T cells harness the natural T cell receptor complex to recognize and **** cancer cells using the full power of T cell signaling pathways independent of HLA.
Oncology Therapeutics - Cardiff Oncology
Cardiff Oncology is a clinical-stage company with the singular mission of developing new oncology therapeutic options for cancer patients.
Mozart Therapeutics | CD8 T regulatory cells | Autoimmune and Inflammatory diseases
Mozart Therapeutics is capitalizing on a novel CD8 T regulatory cell network to develop innovative disease-modifying therapies for autoimmune and inflammatory diseases.
Muvon Therapeutics | Autologous cell therapy technology | Switzerland
MUVON Therapeutics is a Biotech Spin-off from the University of Zurich with the goal of developing and commercializing an autologous cell therapy for the regeneration of skeletal muscle tissue. Our initial area of focus is developing a safe and effective treatment for stress urinary incontinence in
American Gene Technologies: Developing Gene And Cell Therapies
American Gene Technologies™ (AGT) is a gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications. AGT expects its lead candidate for an **** cure to enter the clinic in 2018, and it has developed a patented immuno-oncology approach to attack a variety of epithelial cancers.
A regenerative therapy company - Bone Therapeutics
Bone Therapeutics is a bone cell therapy company specializing in addressing unmet medical needs in the field of bone fracture repair and bone fracture prevention. Bone Therapeutics develops both autologous and allogeneic innovative cell therapy products.
Author: Bone Therapeutics SA
Procella Therapeutics AB - Cell Therapy Solutions
Procella Therapeutics AB is a biotech company focused on developing cardiac stem cell technology with the aim of treating heart failure.
Oyster Point Pharma - Therapies to Address Ophthalmic Disease
We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies to address ophthalmic disease.
BioEclipse Therapeutics™ | NEXT GENERATION OF IMMUNOTHERAPY
BioEclipse Therapeutics™ is a clinical-stage oncology company that uses its proprietary technology to develop the next generation of immuno-oncology therapeutics.
Home - GammaDelta Therapeutics
OUR MISSION Discover GammaDelta Therapeutics GammaDelta Therapeutics is committed to transforming the treatment of patients living with haematological and solid cancers. Our mission is to develop the first effective off the shelf cancer therapy based on one of the body’s own immune cells, a subtype of gamma delta (γδ) T lymphocyte known as
Author: Gammadelta
Spiral Therapeutics - Therapies for Hearing Loss
Spiral is a clinical stage pharmaceutical company developing therapies that target hearing loss and other ear disorders.
Home • TC BioPharm
TC BioPharm is a privately-held, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer.
What else eurekatherapeutics.com alternative websites
Altimmune a clinical stage biopharmaceutical company
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies. Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B, and conjugated immunostimulants for the treatment of cancer. In addition, we are developing intranasal vaccine & therapeutic candidates for anthrax, influenza and COVID-19.
Home - Amphera
Amphera B.V., a clinical stage Dutch life science company, develops dendritic cell therapies for the treatment of cancer.
We build superior ADCs | Iksuda Therapeutics
Iksuda is an emerging biotechnology company focused on developing antibody-based therapies for the treatment of cancer as well as broader based therapeutics. Our main goal is to develop effective therapies to improve patients’ lives. Our mission is to enable improved clinical regimes through cre ...
Author: Base Creative
Helix BioPharma - New Directions in Cancer Therapy
We are a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on our proprietary technological platform.
Ikena Oncology | Biomarker-Driven Cancer Therapeutics
Ikena Oncology is a clinical-stage biotechnology company that discovers and develops patient-directed, biomarker-driven therapies for cancer patients.
Author: Walid
Immune Responses, On Cue - Cue Biopharma
Cue Biopharma, a clinical-stage biopharmaceutical company, is engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells directly within the body to transform the treatment of cancer, infectious diseases and autoimmune diseases. The company’s proprietary platform, Immuno-STAT™ (Selective Targeting and Alteration of T cells) is designed to harness the body’s intrinsic […]
Home - First Wave BioPharma, Inc.
First Wave BioPharma is a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases.
G1 Therapeutics, Inc. | Optimizing Chemotherapy, Advancing Survival
G1 Therapeutics, Inc. is a commercial stage oncology company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer.
AskBio - AAV Gene Therapy Technology & Therapeutics
AskBio is a leading, clinical-stage gene therapy company dedicated to developing AAV gene therapies for genetic and complex disorders. Learn more about our gene therapy technology and current clinical trials.
Cell Therapy Manufacturing and Process Development
Advanced Cell Therapy and Research Institute Singapore facilitates discovery, process development and manufacturing of cellular-based therapeutics. Our goal is to promote and foster the entire value chain of the cellular ecosystem through translational research and development. Visit us today.
Home • Repertoire Immune Medicines
Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to prevent or treat cancer, as well as autoimmune and infectious disease.
AntlerA Therapeutics: Repair | Regenerate | Renew
A regenerative medicines company focused on developing novel protein therapeutics that function by modulating Wnt signaling and other developmental cellular signaling pathways with the goal to control tissue stem cells and unleash tissue repair and rejuvenation
Developing novel vaccines and therapeutic proteins | Medicago
Medicago is a leading clinical-stage biopharmaceutical company using disruptive plant-based and virus-like particle (VLP) technologies to rapidly develop innovative vaccines and protein-based therapeutics for infectious diseases and emerging public health challenges.
Microbiota Restoration Therapy™ for Gastrointestinal Diseases | Rebiotix Inc.
A clinical stage microbiome company developing microbiota restoration therapies for the treatment of gastrointestinal diseases from gut dysbiosis.
Home Page - Cancer Prevention
Cancer Prevention Pharmaceuticals is a clinical stage company developing therapeutics to reduce the risk and recurrence of cancer and rare diseases. CPP’s innovative technology addresses polyamine metabolism, immune regulation and inflammation to reduce cancer risk and impact other diseases. These … Continue reading →
Home - VTV Therapeutics
vTv Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of **** administered small molecule **** candidates to fill significant unmet medical needs. vTv has a pipeline of internally discovered clinical **** candidates led by programs for the treatment of type 1 diabetes and inflammatory disorders. To learn more about our science […]
Pharnext - Pharnext
Pharnext is an advanced clinical-stage biopharmaceutical company developing novel first-in-class therapies for orphan and common diseases with high unmet medical needs, leveraging our artificial intelligence (AI)-based PLEOTHERAPY™ platform.
Breakthrough miRNA therapeutics tackling cancer - InteRNA Technologies
A Dutch clinical-stage biotech company InteRNA Technologies is a Dutch clinical-stage biotech company developing a pipeline of proprietary RNA therapeutics targeting key processes in initiation and progression of human diseases, with a focus on cancer. Selected through its leading microRNA (miRNA) discovery and functional validation technology platform and enabled with a 3rd-generation **** delivery
Atara Bio - Home
Atara Biotherapeutics, Inc. is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases.Leveraging our novel allogeneic EBV T-cell platform, Atara intends to deliver treatments to patients with high unmet medical need. Our platform aims to leverage the unique biology of EBV T cells to channel the power of the immune system and has the potential to...
Author: August
RadioMedix, Inc
RadioMedix, Inc. is a clinical stage biotechnology company, based in Houston, Texas, focused on innovative targeted radiopharmaceuticals for diagnosis, monitoring, and therapy of cancer. The company is developing radiopharmaceuticals for PET imaging and therapeutic (alpha and beta-labeled) radiopharmaceuticals.
Other websites similar as eurekatherapeutics.com
LionTCR | Home
At Lion TCR, over a decade’s worth of basic research, product engineering and development, and pre-clinical/clinical assessment have culminated in our leading product that harnesses the power of a patient’s own immune system to eliminate HBV-related hepatocellular carcinoma. Together with our world-renowned scientific advisors, we continue to develop novel immunotherapies against viral infections and their related cancers afflicting the Asian population.
Audion Therapeutics
Audion Therapeutics is a clinical-stage company dedicated to the development of therapies to treat Hearing Loss About Audion Hearing Loss Acquired Sensorineural Hearing Loss (SNHL), due to aging, exposure to noise or other environmental factors impacts hundreds of millions of people. According to the recently updated World Health Organization estimates, 1 in 4 people worldwide...
Home - Alkahest
Alkahest is a clinical stage biopharmaceutical company targeting neurodegenerative and age-related diseases with transformative therapies derived from a deep understanding of the plasma proteome in aging and disease. Harnessing Chronokines Aging is the dominant risk factor in degenerative diseases, particularly those with no or few therapeutic solutions. Alkahest is decoding the plasma proteome to create …
Celularity Inc. (NASDAQ:CELU)
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells (ASCs), targeting indications across cancer, immunologic, infectious, and degenerative diseases.
Author: Celularity Inc
Byondis | Creating Precision Medicines
We are a clinical stage biopharmaceutical research and development company with around 400 staff, including highly educated scientists and skilled technicians who share the same goal: To create safe and effective precision medicines targeting intractable cancers and autoimmune diseases, improving the standard of care for patients.
Home | Da Volterra
Da Volterra is a clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiota field.Our mission is to discover, develop and bring to market safe and novel therapeutic options, preserving patients’ microbiota to prevent and cure life-threatening diseases.We strive to serve patients by transforming the promise of science into innovative treatments which have the power to improve health and save lives.
PolyPid - Optimized Therapeutics
ABOUT US We are a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes. Our PLEX (Polymer-Lipid Encapsulation matriX) technology is a unique platform that is anchored in the surgical site to provide controlled and continuous delivery of medications. Our product candidates are designed to deliver medications […]
Home -
SOLA Biosciences (Greater Boston, MA) is a pre-clinical-stage biopharmaceutical company focusing on developing transformative gene therapies to treat protein misfolding diseases. SOLA developed a proprietary “JUMP70 (J-domain Upholding Misfolding-Protein for Hsp70 Chaperone)” technology platform designed to harness the power of a patient’s own chaperones to repair disease-causing proteins. SOLA is currently developing eight (8) pipeline … Continue reading "Home"
Cellestia, modulating gene expression
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression in multiple disease areas by selective inhibition of transcription factors in the cell nucleus. The lead compound CB-103 has advanced to Phase 2 successfully treating patients with multi-**** resistant cancers.
Some websites with similar theme to eurekatherapeutics.com include:
Frontotemporal dementia | The Bluefield Project to Cure FTD
The Bluefield Project was established in 2010 to fund research directed towards curing frontotemporal dementia (FTD). FTD is a devastating, early-onset degenerative brain disease and is recognized as a common cause of dementia in people under the age of 60 years.
American College of Bankruptcy
The mission of the College is to honor and recognize distinguished bankruptcy professionals who are qualified for membership in an effort to set standards of achievement for others in the insolvency community.
Natural Killer Cells (NK Cells) for the treatment of cancer
Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.
Adicet Bio | Gamma Delta T cells
Adicet Bio, a pre-clinical stage biotechnology company engaged in the design and development of cutting-edge allogeneic immunotherapies for cancer and other diseases.
XPAT® | Pro-XTEN Platform | T Cell Engagers | Amunix Pharmaceuticals
Amunix is an immuno-oncology company leveraging Pro-XTEN technology platform to discover and develop transformative therapies for patients with cancer.
Financing Senior Housing Since 1992 | LTC Properties Inc.
LTC Properties is a REIT investing in seniors housing and health care through sale-leasebacks, mortgage financing, joint-ventures, construction financing and structured finance solutions.
Oncolytic immunotherapy | CG0070 | CG Oncology
CG Oncology is a clinical-stage biopharmaceutical company focused on the research, acquisition and development of novel immunotherapies.
The Protein Design Revolution Begins Here
Neoleukin is a leader in de novo protein design – utilizing advanced computational methods to build entirely new therapeutic proteins tailor-made to treat immunological disorders, including cancer and autoimmunity.
Vir Biotechnology
Vir is focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.
Engineering Drugs for Personalized Medicines
Engineering Drugs for Personalized Medicines, Plexxikon has earned a reputation as a leader in targeted **** discovery and translational, personalized medicine.
Liver Cancer & T-Cell Therapy | Eureka Connect Me
Learn more about liver cancer and our unique approach to tackling liver cancer at Eureka Connect Me.
More other alternatives for eurekatherapeutics com
Blade Therapeutics
Blade Therapeutics is advancing innovative anti-fibrotic therapies to meet currently unserved patient needs.
Dynavax Technologies | Toll-like Receptor | Vaccines
Dynavax Technologies is focused on leveraging the power of the body’s innate and adaptive immune responses through Toll-like Receptor (TLR) stimulation.
Allakos | AK002 mAb
Allakos is developing therapeutic antibodies that selectively target eosinophils and mast cells, cells that play a significant role in many diseases
Startseite :: KitzlingerHaus
Kitzlinger steht für gesunde, energieeffiziente und wertbeständige Häuser, die höchsten ökologischen Standards genügen und so individuell sind wie die Träume Ihrer Bewohner. Wir bauen Häuser, die zu unseren Kunden passen.
Innovative Targeted and Immune-Mediated Cancer Therapies
Tempest Therapeutics is developing first-in-class small molecule product candidates with broad potential benefit to patients.
Chinook Therapeutics | Atrasentan
Chinook is a clinical-stage biopharmaceutical company discovering, developing and commercializing precision medicines for rare, severe chronic kidney diseases.
Rare Genetic Diseases | Ultragenyx
Ultragenyx is a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. Founded in 2010, the company has rapidly built a diverse portfolio of product candidates with the potential to address diseases for which the unmet medical need is high, the biology for treatment is clear, and for which there are no approved therapies.
IWIRC, International Women's Insolvency & Restructuring Confederation
IWIRC, the premier networking organization for women in the practice of insolvency and restructuring, helps its members achieve productive relationships by providing a range of practice development and networking opportunities that enhance their professional stature within an open and friendly culture.
Bringing ingenuity to drugdevelopment
Corvus Pharmaceuticals is a clinical science-driven biopharmaceutical company focused on the development of cleverly-designed medicines with precise mechanisms of action to improve the lives of patients with the most difficult-to-treat cancers.
OrphoMed Inc. | Gastrointestinal Disorders | Dimer Therapeutics Platform
OrphoMed is a clinical-stage biotechnology company with a proprietary dimer therapeutics platform. The company is focused on developing best-in class treatments for patients with gastrointestinal disorders.
Imetelstat | Myelofibrosis | Myelodysplastic Syndrome | Geron
Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Communications & Power Industries
Communications & Power Industries (CPI) provides microwave, radio frequency (RF), power and control solutions for defense, communications, medical, scientific and industrial applications. Products include: VEDs, klystrons, TWTs, TWTAs, CFAs, satcom amplifiers, HPAs, SSPAs, LNAs, LNBs, power grid devices, advanced antenna systems, BUCs, solid-state devices, IMAs, EIKs, magnetrons, gyrotrons, medical x-ray generators, medical digital imaging systems, telemetry systems, radomes, transmitters, microwave switches, RF decks, receiver protectors, pressure windows, helix devices, coupled cavity devices
NovoMedix LLC
NovoMedix is conquering Cancer and Fibrosis by IL-11 inhibition and modulation of key regulatory pathways
Zosano Pharma | Migraine treatment | M207 | zolmitriptan
Zosano Pharma is an emerging CNS company focusing on providing rapid symptom relief to patients, using known therapeutics with well-established safety and efficacy.
